Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
  • Info
    • Permissions
    • Continuing Education
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
  • Info
    • Permissions
    • Continuing Education
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
Research ArticleCovid Commentaries

Post–COVID-19 New Normal for Molecular Imaging Departments: A United Kingdom Perspective

Jessica Williams, Emma Meadows and Manrita Singh
Journal of Nuclear Medicine Technology September 2020, 48 (3) 227-233; DOI: https://doi.org/10.2967/jnmt.120.252635
Jessica Williams
1Department of Molecular Imaging, HCA Healthcare UK, London, England; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma Meadows
1Department of Molecular Imaging, HCA Healthcare UK, London, England; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manrita Singh
2Department of Molecular Imaging, University College London Hospital, London, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Coronavirus disease 2019 has changed the way the world is navigated and has had a massive impact on health care. Depending on where you are in the world, the guidance on dealing with potential infected patients is varied. With the high risk of a second wave, it is important to learn from initial responses to plan for the future. With proper preparation, it is possible to minimize exposure and risk of contamination to individuals visiting molecular imaging departments. Such precautions will help departments operate at full capacity. From the widespread nature of this pandemic, a global perspective can be useful; what follows is the United Kingdom’s perspective.

  • molecular imaging
  • COVID-19
  • nuclear medicine
  • pandemic
  • U.K

Footnotes

  • Published online Jul. 24, 2020.

View Full Text

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

SNMMI members

SNMMI Member Login

Login to the site using your SNMMI member credentials

Individuals

Non-Member Login

Login as an individual user

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 48 (3)
Journal of Nuclear Medicine Technology
Vol. 48, Issue 3
September 1, 2020
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Post–COVID-19 New Normal for Molecular Imaging Departments: A United Kingdom Perspective
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Post–COVID-19 New Normal for Molecular Imaging Departments: A United Kingdom Perspective
Jessica Williams, Emma Meadows, Manrita Singh
Journal of Nuclear Medicine Technology Sep 2020, 48 (3) 227-233; DOI: 10.2967/jnmt.120.252635

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Post–COVID-19 New Normal for Molecular Imaging Departments: A United Kingdom Perspective
Jessica Williams, Emma Meadows, Manrita Singh
Journal of Nuclear Medicine Technology Sep 2020, 48 (3) 227-233; DOI: 10.2967/jnmt.120.252635
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • ACUTE IMPACT ON PRACTICE
    • POST–COVID-19 PRACTICE
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • A Virtual Success
  • Google Scholar

More in this TOC Section

  • Nuclear Medicine Clinical Practice in the United States During the COVID-19 Era and Beyond
  • Post–COVID-19 New Normal for Nuclear Medicine Practice: An Australasian Perspective
Show more Covid Commentaries

Similar Articles

Keywords

  • Molecular Imaging
  • COVID-19
  • nuclear medicine
  • Pandemic
  • U.K
SNMMI

© 2021 Journal of Nuclear Medicine Technology

Powered by HighWire